PNC-27 is studied in tissue regeneration and repair research, including cell and animal models. PNC-27 binds membrane-bound HDM-2, which is overexpressed on the surface of many cancer cells, inducing pore formation in the plasma membrane that selectively drives necrosis in those cells while sparing normal cells.
Studied in preclinical cancer research as a model system for a pore-forming, HDM-2-directed killing mechanism that operates independently of classical p53-mediated apoptosis.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.